NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Monday that it plans to offer $250 million aggregate principal amount of convertible senior notes due 2021.

The notes will be offered and sold to qualified institutional buyers. The Sunnyvale, Calif.-based firm added that it intends to grant the notes' initial purchasers the option to purchase up to $37.5 million amount of notes to cover any overallotments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.